These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38587386)

  • 1. Differentiation and Characterization of Osteoclasts from Human Induced Pluripotent Stem Cells.
    Blümke A; Simon J; Leber E; Scatena M; Giachelli CM
    J Vis Exp; 2024 Mar; (205):. PubMed ID: 38587386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an in vitro culture method for stepwise differentiation of mouse embryonic stem cells and induced pluripotent stem cells into mature osteoclasts.
    Nishikawa K; Iwamoto Y; Ishii M
    J Bone Miner Metab; 2014 May; 32(3):331-6. PubMed ID: 24366621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins.
    Blümke A; Ijeoma E; Simon J; Wellington R; Purwaningrum M; Doulatov S; Leber E; Scatena M; Giachelli CM
    Stem Cell Res Ther; 2023 Nov; 14(1):319. PubMed ID: 37936199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.
    Grigoriadis AE; Kennedy M; Bozec A; Brunton F; Stenbeck G; Park IH; Wagner EF; Keller GM
    Blood; 2010 Apr; 115(14):2769-76. PubMed ID: 20065292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence of osteoclast precursors in colonies cloned in the presence of hematopoietic colony-stimulating factors.
    Yamazaki H; Kunisada T; Yamane T; Hayashi SI
    Exp Hematol; 2001 Jan; 29(1):68-76. PubMed ID: 11164107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of osteoclast differentiation protocols from human induced pluripotent stem cells of different tissue origins.
    Blümke A; Ijeoma E; Simon J; Wellington R; Purwaningrum M; Doulatov S; Leber E; Scatena M; Giachelli CM
    Res Sq; 2023 Jul; ():. PubMed ID: 37461708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand.
    Itoh K; Udagawa N; Katagiri T; Iemura S; Ueno N; Yasuda H; Higashio K; Quinn JM; Gillespie MT; Martin TJ; Suda T; Takahashi N
    Endocrinology; 2001 Aug; 142(8):3656-62. PubMed ID: 11459815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption.
    Kim MS; Day CJ; Selinger CI; Magno CL; Stephens SR; Morrison NA
    J Biol Chem; 2006 Jan; 281(2):1274-85. PubMed ID: 16280328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro.
    Quinn JM; Elliott J; Gillespie MT; Martin TJ
    Endocrinology; 1998 Oct; 139(10):4424-7. PubMed ID: 9751528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoralen and Bakuchiol Ameliorate M-CSF Plus RANKL-Induced Osteoclast Differentiation and Bone Resorption Via Inhibition of AKT and AP-1 Pathways in Vitro.
    Chai L; Zhou K; Wang S; Zhang H; Fan N; Li J; Tan X; Hu L; Fan X
    Cell Physiol Biochem; 2018; 48(5):2123-2133. PubMed ID: 30110702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
    Flanagan AM; Massey HM; Wilson C; Vellodi A; Horton MA; Steward CG
    Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An adherent condition is required for formation of multinuclear osteoclasts in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor kappa B ligand.
    Miyamoto T; Arai F; Ohneda O; Takagi K; Anderson DM; Suda T
    Blood; 2000 Dec; 96(13):4335-43. PubMed ID: 11110710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors.
    Shalhoub V; Faust J; Boyle WJ; Dunstan CR; Kelley M; Kaufman S; Scully S; Van G; Lacey DL
    J Cell Biochem; 1999 Feb; 72(2):251-61. PubMed ID: 10022507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal and spatial localization of osteoclasts in colonies from embryonic stem cells.
    Hemmi H; Okuyama H; Yamane T; Nishikawa S; Nakano T; Yamazaki H; Kunisada T; Hayashi S
    Biochem Biophys Res Commun; 2001 Jan; 280(2):526-34. PubMed ID: 11162550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FLT3 ligand can substitute for macrophage colony-stimulating factor in support of osteoclast differentiation and function.
    Lean JM; Fuller K; Chambers TJ
    Blood; 2001 Nov; 98(9):2707-13. PubMed ID: 11675341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
    Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
    Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine A(2A) receptor ligation inhibits osteoclast formation.
    Mediero A; Kara FM; Wilder T; Cronstein BN
    Am J Pathol; 2012 Feb; 180(2):775-86. PubMed ID: 22138579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential requirements for SCL/tal-1, GATA-2, macrophage colony-stimulating factor, and osteoclast differentiation factor/osteoprotegerin ligand in osteoclast development.
    Yamane T; Kunisada T; Yamazaki H; Nakano T; Orkin SH; Hayashi SI
    Exp Hematol; 2000 Jul; 28(7):833-40. PubMed ID: 10907645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The generation of highly enriched osteoclast-lineage cell populations.
    Quinn JM; Whitty GA; Byrne RJ; Gillespie MT; Hamilton JA
    Bone; 2002 Jan; 30(1):164-70. PubMed ID: 11792580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression.
    Karsdal MA; Hjorth P; Henriksen K; Kirkegaard T; Nielsen KL; Lou H; Delaissé JM; Foged NT
    J Biol Chem; 2003 Nov; 278(45):44975-87. PubMed ID: 12933809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.